CASP3 and prostate carcinoma: The treatment with different concentration Camptothecin could affect cell morphology and increase the cell early apoptosis rate of human prostate cancer cell line PC-3 (IC50, 23.25 μM) by affecting the expressions of Bax, cleaved caspase-3 and Bcl-2 (20).